Cohance Lifesciences shares hit a fresh intraday high on Monday even as its Andhra Pradesh API plant received five USFDA observations. This rise comes even...
Cipla has disclosed that the USFDA classified its InvaGen New York plant inspection as Voluntary Action Indicated, closing the regulatory review. The plant is Unit...
Zydus Lifesciences has received final USFDA approval for its generic Ascorbic Acid Injection, used to treat scurvy. The approval covers the drug in two strengths,...